- Home
- CPOP vs CLDI Comparison
CPOP vs CLDI Comparison
Compare CPOP & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- CLDI
- Stock Information
- Founded
- CPOP 2007
- CLDI 2014
- Country
- CPOP China
- CLDI United States
- Employees
- CPOP N/A
- CLDI N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPOP Consumer Discretionary
- CLDI Health Care
- Exchange
- CPOP Nasdaq
- CLDI Nasdaq
- Market Cap
- CPOP 17.9M
- CLDI 18.1M
- IPO Year
- CPOP 2021
- CLDI N/A
- Fundamental
- Price
- CPOP $1.21
- CLDI $2.16
- Analyst Decision
- CPOP
- CLDI Strong Buy
- Analyst Count
- CPOP 0
- CLDI 3
- Target Price
- CPOP N/A
- CLDI $16.67
- AVG Volume (30 Days)
- CPOP 99.7K
- CLDI 3.5M
- Earning Date
- CPOP 11-29-2024
- CLDI 11-12-2024
- Dividend Yield
- CPOP N/A
- CLDI N/A
- EPS Growth
- CPOP N/A
- CLDI N/A
- EPS
- CPOP N/A
- CLDI N/A
- Revenue
- CPOP $47,381,918.00
- CLDI N/A
- Revenue This Year
- CPOP N/A
- CLDI N/A
- Revenue Next Year
- CPOP N/A
- CLDI N/A
- P/E Ratio
- CPOP N/A
- CLDI N/A
- Revenue Growth
- CPOP 155.52
- CLDI N/A
- 52 Week Low
- CPOP $0.91
- CLDI $0.73
- 52 Week High
- CPOP $9.67
- CLDI $26.30
- Technical
- Relative Strength Index (RSI)
- CPOP 48.70
- CLDI 57.07
- Support Level
- CPOP $1.18
- CLDI $2.10
- Resistance Level
- CPOP $1.45
- CLDI $2.51
- Average True Range (ATR)
- CPOP 0.08
- CLDI 0.43
- MACD
- CPOP 0.00
- CLDI 0.04
- Stochastic Oscillator
- CPOP 17.54
- CLDI 36.86
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from our Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.